Press Releases

Dr. Natalie Uy, a leading pediatric nephrologist, has been named chief of the Division of Pediatric Nephrology in the Department of Pediatrics at Weill Cornell Medicine and NewYork-Presbyterian Komansky Children’s Hospital, effective April 17.

Dr. Omar Abdul-Rahman, a leading specialist in pediatric genetic medicine, has been named chief of the Division of Medical Genetics in the Department of Pediatrics at Weill Cornell Medicine and NewYork-Presbyterian Komansky Children’s Hospital, effective March 1.

Interim Dean Dr. Francis Lee sent the following message Jan. 26 to the Weill Cornell Medicine community....

The Drukier Prize honors an early-career pediatrician whose research promises to make important contributions toward improving the health of children and adolescents.

NewYork-Presbyterian is expanding its renowned heart transplant program, one of the largest and most experienced heart transplant programs in the nation, and increasing access to its world-class heart failure care.

Weill Cornell Medicine was awarded a $61.9 million grant from the National Institute of Health’s National Center for Advancing Translational Sciences (NCATS) to continue funding its Clinical and Translational Science Center (CTSC) until 2027.

Dr. Jedd Wolchok, an internationally acclaimed medical oncologist whose innovations in immunotherapy have revolutionized melanoma treatment, has been recruited as the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, effective Sept. 12.

Dr. Denise Howard, a leading obstetrician and gynecologist who specializes in gynecologic surgery and women’s reproductive health, has been appointed chief of the Department of Obstetrics and Gynecology at NewYork-Presbyterian Brooklyn Methodist Hospital.

Dr. Camilia Martin, an esteemed physician-scientist who combines clinical care and innovative research on neonatal nutrition to improve outcomes for premature and newborn babies, has been named chief of the Division of Newborn Medicine at Weill Cornell Medicine and NewYork-Presbyterian Komansky Children’s Hospital, effective May 1.

Dr. Larissa V. Rodríguez, a distinguished physician-scientist and urologic surgeon who specializes in female pelvic medicine and reconstructive surgery, has been named chair of the Department of Urology at Weill Cornell Medicine and urologist-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center

Dr. Erick Forno, a physician-scientist who investigates the risk factors and genomic mechanisms underlying childhood asthma, has been awarded the sixth annual Gale and Ira Drukier Prize in Children’s Health Research, Weill Cornell Medicine announced today.     

Weill Cornell Medicine today celebrated the opening of a new, multidisciplinary medical practice in Long Island City. The comprehensive practice, in partnership with NewYork-Presbyterian, expands access to the institutions’ leading physicians in Queens and offers a one-stop destination for some of the most in-demand specialties for adults and children.

Dr. Julia Cron has been appointed chief and vice chair of the Department of Obstetrics and Gynecology at NewYork-Presbyterian Lower Manhattan Hospital, effective Oct. 1.

Dr. Robert S. Brown, an outstanding physician-scientist who combines clinical care with research focused on improving outcomes for patients with liver diseases, has been named chief of the Division of Gastroenterology and Hepatology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective Aug. 1.

Dr. Brian DeRubertis, a leading vascular surgeon and researcher who develops innovative approaches and surgical techniques for treating conditions affecting the circulatory system, has been named chief of the Division of Vascular and Endovascular Surgery at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center.

NewYork-Presbyterian Hospital is ranked No. 1 in New York and No. 7 in the nation by U.S. News & World Report. This is the 21st consecutive year NewYork-Presbyterian Hospital is the top-ranked hospital in New York.

Building on a legacy of groundbreaking advances in medicine and science, Weill Cornell Medicine today launched an ambitious $1.5 billion campaign—with more than $750 million already raised—that will harness emerging biomedical innovations to bring exemplary care to patients and create enduring change in medicine.

About 12,000 bacteria and viruses collected in a sampling from public transit systems and hospitals around the world from 2015 to 2017 had never before been identified.

Dr. Katharine Hsu, an esteemed physician-scientist who specializes in immunology research and treatment of blood cancers, has been named director of the Tri-Institutional M.D.-Ph.D. Program, a joint program between Weill Cornell Medicine, The Rockefeller University and Memorial Sloan Kettering Cancer Center.

Weill Cornell Medicine will launch a suite of innovative programs to foster and sustain a more diverse faculty through the support of a $5 million grant from the Mastercard Impact Fund.